Isoprenaline Hydrochloride Macure Pharma Uk

Isoprenaline Hydrochloride, the active ingredient in Isoprenaline Hydrochloride Macure Pharma Uk, is a beta‑adrenergic agonist presented as a sterile solution for intravenous use. It is employed to increase heart rate and contractility in bradycardia or heart block and to produce bronchodilation in asthma and bronchospasm patients.

GNH USA supplies Isoprenaline Hydrochloride Macure Pharma Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoprenaline Hydrochloride acts on the sympathetic nervous system to manage conditions where increased cardiac output or airway relaxation is required.

- Bradycardia: raises heart rate to restore adequate cardiac output. - Heart block: improves atrioventricular conduction to maintain rhythm. - Asthma: relaxes bronchial smooth muscle to ease breathing. - Bronchospasm: dilates airways during acute constriction episodes.

Isoprenaline Hydrochloride may cause a range of adverse reactions, some of which are dose‑related and reversible.

Common Side Effects: - Tachycardia: rapid increase in heart rate. - Tremor: fine shaking of hands or limbs. - Headache: mild to moderate pain. - Nausea: feeling of stomach upset.

Serious or Rare Side Effects: - Arrhythmias: potentially life‑threatening irregular heartbeats. - Myocardial ischemia: reduced blood flow to heart muscle. - Severe hypotension: dangerous drop in blood pressure. - Anaphylactic reaction: sudden severe allergic response.

Use of Isoprenaline Hydrochloride requires careful clinical monitoring and patient assessment.

- Cardiac monitoring: continuously observe heart rhythm and rate. - Ischemic heart disease: assess risk before administration. - Hypertension: use cautiously in patients with high blood pressure. - Pheochromocytoma: avoid use in this condition. - Store at controlled room temperature: keep in original container, protect from light and moisture.

Isoprenaline Hydrochloride can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Beta‑blockers: antagonize therapeutic effects. - Calcium channel blockers: may precipitate severe hypotension. - MAO inhibitors: increase risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolyte balance and blood pressure. - Antihypertensives: adjust dosing to avoid excessive blood pressure reduction.